Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 54

Similar articles for PubMed (Select 20586967)

1.
2.

Why are antiretroviral treatment patients lost to follow-up? A qualitative study from South Africa.

Miller CM, Ketlhapile M, Rybasack-Smith H, Rosen S.

Trop Med Int Health. 2010 Jun;15 Suppl 1:48-54. doi: 10.1111/j.1365-3156.2010.02514.x.

3.

Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approach.

Geng EH, Bangsberg DR, Musinguzi N, Emenyonu N, Bwana MB, Yiannoutsos CT, Glidden DV, Deeks SG, Martin JN.

J Acquir Immune Defic Syndr. 2010 Mar;53(3):405-11. doi: 10.1097/QAI.0b013e3181b843f0.

4.

Early loss to follow up after enrolment in pre-ART care at a large public clinic in Johannesburg, South Africa.

Larson BA, Brennan A, McNamara L, Long L, Rosen S, Sanne I, Fox MP.

Trop Med Int Health. 2010 Jun;15 Suppl 1:43-7. doi: 10.1111/j.1365-3156.2010.02511.x.

5.

ART treatment costs and retention in care in Kenya: a cohort study in three rural outpatient clinics.

Larson BA, Bii M, Henly-Thomas S, McCoy K, Sawe F, Shaffer D, Rosen S.

J Int AIDS Soc. 2013 Jan 2;16:18026. doi: 10.7448/IAS.16.1.18026.

6.

Characteristics and outcomes of adult patients lost to follow-up at an antiretroviral treatment clinic in johannesburg, South Africa.

Dalal RP, Macphail C, Mqhayi M, Wing J, Feldman C, Chersich MF, Venter WD.

J Acquir Immune Defic Syndr. 2008 Jan 1;47(1):101-7.

PMID:
17971708
7.

The social and clinical characteristics of patients on antiretroviral therapy who are 'lost to follow-up' in KwaZulu-Natal, South Africa: a prospective study.

Peltzer K, Ramlagan S, Khan MS, Gaede B.

SAHARA J. 2011;8(4):179-86. doi: 10.1080/17290376.2011.9725002.

PMID:
23236959
8.

Prognostic value of virological and immunological responses after 6 months of antiretroviral treatment in adults with HIV-1 infection in sub-Saharan Africa.

De Luca A, Marazzi MC, Mancinelli S, Ceffa S, Altan AM, Buonomo E, Prosperi MC, Pedruzzi B, Noorjehan AM, Scarcella P, Liotta G, Palombi L.

J Acquir Immune Defic Syndr. 2012 Mar 1;59(3):236-44. doi: 10.1097/QAI.0b013e31824276e9.

PMID:
22327246
9.

Enhancing adherence to antiretroviral therapy at the HIV clinic in resource constrained countries; the Tanzanian experience.

Mugusi F, Mugusi S, Bakari M, Hejdemann B, Josiah R, Janabi M, Aboud S, Aris E, Swai H, Mhalu F, Biberfeld G, Pallangyo K, Sandstrom E.

Trop Med Int Health. 2009 Oct;14(10):1226-32. doi: 10.1111/j.1365-3156.2009.02359.x. Epub 2009 Sep 3.

10.

When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African cost-effectiveness study.

Badri M, Cleary S, Maartens G, Pitt J, Bekker LG, Orrell C, Wood R.

Antivir Ther. 2006;11(1):63-72.

PMID:
16518961
11.

Strategies to improve patient retention on antiretroviral therapy in sub-Saharan Africa.

Harries AD, Zachariah R, Lawn SD, Rosen S.

Trop Med Int Health. 2010 Jun;15 Suppl 1:70-5. doi: 10.1111/j.1365-3156.2010.02506.x.

12.

Cost and resource use of patients on antiretroviral therapy in the urban and semiurban public sectors of South Africa.

Meyer-Rath G, Miners A, Santos AC, Variava E, Venter WD.

J Acquir Immune Defic Syndr. 2012 Nov 1;61(3):e25-32. doi: 10.1097/QAI.0b013e31826cc575.

PMID:
22895437
13.

Lost to follow up: contributing factors and challenges in South African patients on antiretroviral therapy.

Maskew M, MacPhail P, Menezes C, Rubel D.

S Afr Med J. 2007 Sep;97(9):853-7.

14.

Community-based follow-up for late patients enrolled in a district-wide programme for antiretroviral therapy in Lusaka, Zambia.

Krebs DW, Chi BH, Mulenga Y, Morris M, Cantrell RA, Mulenga L, Levy J, Sinkala M, Stringer JS.

AIDS Care. 2008 Mar;20(3):311-7. doi: 10.1080/09540120701594776.

PMID:
18351478
15.

Individual and contextual factors influencing patient attrition from antiretroviral therapy care in an urban community of Lusaka, Zambia.

Musheke M, Bond V, Merten S.

J Int AIDS Soc. 2012 Jun 14;15 Suppl 1:1-9. doi: 10.7448/IAS.15.3.17366.

16.

Risk factors, barriers and facilitators for linkage to antiretroviral therapy care: a systematic review.

Govindasamy D, Ford N, Kranzer K.

AIDS. 2012 Oct 23;26(16):2059-67. doi: 10.1097/QAD.0b013e3283578b9b. Review.

PMID:
22781227
17.

Adherence to antiretroviral therapy in patients participating in a graduated cost recovery program at an HIV care center in South India.

Batavia AS, Balaji K, Houle E, Parisaboina S, Ganesh AK, Mayer KH, Solomon S.

AIDS Behav. 2010 Aug;14(4):794-8. doi: 10.1007/s10461-009-9663-6.

PMID:
20052529
18.

Cost of a dedicated ART clinic.

Harling G, Bekker LG, Wood R.

S Afr Med J. 2007 Aug;97(8):593-6.

19.

Efficacy of a lay health worker led group antiretroviral medication adherence training among non-adherent HIV-positive patients in KwaZulu-Natal, South Africa: results from a randomized trial.

Peltzer K, Ramlagan S, Jones D, Weiss SM, Fomundam H, Chanetsa L.

SAHARA J. 2012 Nov;9(4):218-26. doi: 10.1080/17290376.2012.745640.

PMID:
23234350
20.

The outcomes and outpatient costs of different models of antiretroviral treatment delivery in South Africa.

Rosen S, Long L, Sanne I.

Trop Med Int Health. 2008 Aug;13(8):1005-15. doi: 10.1111/j.1365-3156.2008.02114.x. Epub 2008 Jul 8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk